Your browser doesn't support javascript.
Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo, from March to June 2020.
Bepouka, Ben Izizag; Mandina, Madone; Makulo, Jean Robert; Longokolo, Murielle; Odio, Ossam; Mayasi, Nadine; Pata, Tresor; Nsangana, Godelive; Tshikangu, Felly; Mangala, Donatien; Maheshe, Dupont; Nkarnkwin, Serge; Muamba, Jonathan; Ndaie, Gorby; Ngwizani, Rodrigue; Yanga, Yves; Nkodila, Aliocha; Keke, Hervé; Kokusa, Yamin; Lepira, Francois; Kashongwe, Innocent; Mbula, Marcel; Kayembe, Jean Marie; Situakibanza, Hippolyte.
  • Bepouka BI; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Mandina M; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Makulo JR; Unit of Nephrology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Longokolo M; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Odio O; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Mayasi N; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Pata T; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Nsangana G; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Tshikangu F; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Mangala D; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Maheshe D; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Nkarnkwin S; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Muamba J; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Ndaie G; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Ngwizani R; Unit of Reanimation, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Yanga Y; Unit of Reanimation, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Nkodila A; Unit of Vaccinology, World Health Organization, Kinshasa, Democratic Republic of the Congo.
  • Keke H; Department of Epidemiology, Ministry of Health, Kinshasa, Democratic Republic of the Congo.
  • Kokusa Y; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Lepira F; Unit of Nephrology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Kashongwe I; Unit of Pneumology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Mbula M; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Kayembe JM; Unit of Pneumology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Situakibanza H; Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
Pan Afr Med J ; 37: 105, 2020.
Article in English | MEDLINE | ID: covidwho-1005096
ABSTRACT

INTRODUCTION:

since the 1st case of coronavirus disease 2019 (COVID-19) in Kinshasa on March 10th2020, mortality risk factors have not yet been reported. The objectives of the present study were to assess survival and to identify predictors of mortality in COVID-19 patients at Kinshasa University Hospital.

METHODS:

a retrospective cohort study was conducted, 141 COVID-19 patients admitted at the Kinshasa University Hospital from March 23 to June 15, 2020 were included in the study. Kaplan Meier's method was used to described survival. Predictors of mortality were identified by COX regression models.

RESULTS:

of the 141 patients admitted with COVID-19, 67.4 % were men (sex ratio 2H 1F); their average age was 49.6±16.5 years. The mortality rate in hospitalized patients with COVID-19 was 29% during the study period with 70% deceased within 24 hours of admission. Survival was decreased with the presence of hypertension, diabetes mellitus, low blood oxygen saturation (BOS), severe or critical stage disease. In multivariate analysis, age between 40 and 59 years [adjusted Hazard Ratio (aHR) 4.07; 95% CI 1.16 - 8.30], age at least 60 years (aHR 6.65; 95% CI 1.48-8.88), severe or critical COVID-19 (aHR 14.05; 95% CI 6.3-15.67) and presence of dyspnea (aHR 5.67; 95% CI 1.46-21.98) were independently and significantly associated with the risk of death.

CONCLUSION:

older age, severe or critical COVID-19 and dyspnea on admission were potential predictors of mortality in patients with COVID-19. These predictors may help clinicians identify patients with a poor prognosis.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: English Journal: Pan Afr Med J Year: 2020 Document Type: Article Affiliation country: Pamj.2020.37.105.25279

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: English Journal: Pan Afr Med J Year: 2020 Document Type: Article Affiliation country: Pamj.2020.37.105.25279